The use of talcum powder by women has been associated with an increased risk of ovarian cancer. If you or someone you know has used talcum powder around the perineum, or genital area, and has been diagnosed with ovarian cancer, you may have a talcum powder claim.
When choosing an IUD as your form of birth control, you rely on manufacturers to provide safe, dependable products, and to be forthcoming about the severity of potential risks. However, thousands have reported severe complications, including deaths to the FDA, allegedly caused by Paragard®.
If your vehicle is one of the millions impacted by the recall of Takata airbags, you were likely shocked to learn that you were—or still are—driving around with a very dangerous airbag that could seriously injure you or your passengers.
The U.S. Food and Drug Administration sent a warning letter to Allergan, now AbbVie, reprimanding the medical device manufacturer for serious deficiencies in Allergan’s post-approval studies of its recalled breast implants, which have been linked to an increased risk of cancer.
Recent changes to New Jersey state law in May 2019 that broadened the statute of limitations, or the time in which a person can file a claim, for civil childhood sexual abuse claims are constitutional, Morris County’s Superior Court Judge Paul Bogaard ruled.
Johnson & Johnson announced it will cease production of its talc-based baby powder products in the U.S. and Canada amid thousands of lawsuits alleging the product contains asbestos and caused cancer. Products will continue to be sold by retailers until supplies run out.
Litigation concerning claims that the popular antacid medication Zantac causes cancer continues to move forward with U.S. District Judge Robin Rosenberg on May 8, 2020, appointing attorneys to lead the multidistrict litigation, a national consolidation of individual cases.
Eleven Motley Rice attorneys were selected as a 2020 Super Lawyers® or Rising Stars for South Carolina, Washington, D.C., and West Virginia. Super Lawyers recognition represents no more than 5 percent of attorneys in each state and the Rising Stars list makes up no more than 2.5 percent of attorneys in a state.
Recalls involving the name-brand heartburn drug Zantac (ranitidine) and similar generic versions culminated April 1 in the FDA asking drug manufacturers to immediately withdraw all prescription and over-the-counter ranitidine products, including generic ones, from the U.S. market due to concerns that they may contain toxic N-Nitrosodimethylamine (NDMA).
Motley Rice, as co-lead and trial counsel for end-payor plaintiffs, helped reach a $62.5 million class action settlement to resolve claims alleging pharmaceutical drug manufacturers engaged in anticompetitive conduct to delay market entry of generic Loestrin 24 FE.
Airbag manufacturer Takata Corp., announced yet another major recall of 10 million potentially defective airbag inflators, the latest in a series that amounted to the largest automotive recall in U.S. history.
Our attorneys have a strong track record of landmark action for consumer and worker protection, beginning with asbestos and tobacco and continuing today in a wide variety of litigation. We're honored to be recognized by many groups including these below. Selection criteria for each of the awards can be found here.
Pharmaceuticals Firm of the Year 2020
Insurance Liability Firm of the Year 2020
Bankruptcy Law 2019
Fighting for justice
Our lives and those of the people we love can change in an instant. Whether you were blindsided by an unexpected diagnosis or are finding your way following a devastating accident or financial loss, we're here to support those who need us. We focus on the following litigation areas: